类两性纳米纤维:用于心血管治疗的先进药物输送平台
Katherine I Foley1, Adelso Tejada Jackson1, Nick D Tsihlis1,2
1Department of Surgery, University of Virginia, Charlottesville, VA , USA.
Expert opinion on drug delivery
|February 14, 2026
概括
类两性纳米纤维显示出作为心血管疾病的药物输送载体的前景,提供了一种新的治疗方法. 对大型动物模型的进一步研究和抗氧化剂的结合可能会提高它们的有效性.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 心血管医学 心血管医学
背景情况:
- 心血管疾病 (CVD) 对全球健康造成重大负担,目前治疗方法的局限性.
- 新型治疗策略对于解决心血管疾病管理中未得到满足的需求至关重要.
- 两 (PA) 纳米纤维正在成为心血管应用中向药物输送的潜在解决方案.
研究的目的:
- 审查类两纳米纤维作为心血管疾病的药物输送载体的潜力.
- 讨论PA纳米纤维的分子结构,自我组装和生理适应性.
- 突出成功和未来发展方向在开发基于PA的CVD纳米疗法.
主要方法:
- 使用PubMed与相关关键词进行的文献搜索.
- 识别和审查关于双纳米纤维和心血管药物输送的出版物.
- 交叉引用已识别的论文以找到其他相关研究.
主要成果:
- PA纳米纤维具有理想的分子架构和自我组装特性,用于药物输送.
- 这些纳米纤维在生理条件下表现出适应性和耐用性.
- 已经报告了PA纳米纤维在针对心血管疾病的向纳米疗法中的众多成功应用.
结论:
- PA纳米纤维代表了纳米疗法在心血管疾病治疗中的一个有前途的平台.
- 未来的研究应该专注于大型动物模型评估,目标发现,可扩展的生产和新的治疗结合.
- 将抗氧化剂与PA纳米纤维相结合可能为心血管疾病提供协同治疗效果.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.3K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.3K
Antipsychotic Drugs: Therapeutic Uses and Side Effects
864
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
864
Therapeutic Drug Monitoring: Drug Analysis Methods
216
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
216
Therapeutic Drug Monitoring: Affecting Factors
256
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
256
Drug Delivery: Overview
937
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
937
Therapeutic Drug Monitoring: Overview and Classification
381
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
381


